US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 854 participants.
Also called NCT05127915
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 854 participants
- Registry
-
NCT05127915
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05127915. Randomized; single masking; primary purpose prevention. Start 2023-01-27 (actual); primary completion 2026-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism
- Condition
- Pulmonary Embolism
- Intervention (Device)
- Adient absorbable filter + best practice VTE prophylaxis
- Intervention (Device)
- best practice VTE prophylaxis
- Lead sponsor
- Adient Medical
- Collaborator
- Avania
- Collaborator
- ICON plc
Record details
- Record id
cardio:ct-nct05127915- Content hash
678e63ce8bb6e22c7f05f2c71bf05609b71d1d75b43d28edee9f084b41836553